<code id='A8CCC05CFF'></code><style id='A8CCC05CFF'></style>
    • <acronym id='A8CCC05CFF'></acronym>
      <center id='A8CCC05CFF'><center id='A8CCC05CFF'><tfoot id='A8CCC05CFF'></tfoot></center><abbr id='A8CCC05CFF'><dir id='A8CCC05CFF'><tfoot id='A8CCC05CFF'></tfoot><noframes id='A8CCC05CFF'>

    • <optgroup id='A8CCC05CFF'><strike id='A8CCC05CFF'><sup id='A8CCC05CFF'></sup></strike><code id='A8CCC05CFF'></code></optgroup>
        1. <b id='A8CCC05CFF'><label id='A8CCC05CFF'><select id='A8CCC05CFF'><dt id='A8CCC05CFF'><span id='A8CCC05CFF'></span></dt></select></label></b><u id='A8CCC05CFF'></u>
          <i id='A8CCC05CFF'><strike id='A8CCC05CFF'><tt id='A8CCC05CFF'><pre id='A8CCC05CFF'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:65985
          Adobe

          Hospitals and medical groups say they’re still reeling from the effects of the cyberattack on a UnitedHealth Group subsidiary, but the massive company at the center of the debacle has so far emerged largely unscathed, with executives on Tuesday praising its strength and resilience.

          The almost $8 billion UnitedHealth made on operations in the first three months of 2024 was roughly the same as the prior-year period. Despite the Change Healthcare cyberattack, the health insurance, provider, and technology conglomerate reaffirmed its adjusted earnings outlook for the year, and its share price grew more than 5% by market close.

          advertisement

          Ultimately, UnitedHealth said it’ll take an up to $1.6 billion hit from the cyberattack this year, a drop in the bucket for a company that’s expected to generate $400 billion in revenue.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          St. Louis police protesters begin picking up checks in $4.9 million settlement
          St. Louis police protesters begin picking up checks in $4.9 million settlement

          FILE-ProtestersgatherinSt.Louis,Sept.15,2017,afterajudgefoundawhiteformerSt.Louispoliceofficer,Jason

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

          CourtesySanofiLONDON—Inabidtoexpanditspipelineofinflammation-targetingdrugs,SanofisaidTuesdayitwasac